Stryker LFIT Anatomic CoCr V40 Femoral Head Recall Stryker issued an "Urgent Medical Device Recall Notification " to surgeons in August 2016, warning that certain LFIT V40 Femoral Heads had been associated with a higher-than-expected number of complaints involving taper lock failure. The U.S. Food & Drug Administration (FDA) later designated Stryker's notification a Class II medical device recall, which indicates that the affected hip replacement components could cause temporary or medically reversible health consequences. Patients who experience taper lock failure are at risk for serious complications that may necessitate revision of their hip implant, including: The JPML initially transferred six Stryker hip replacement lawsuits to the District of Massachusetts. However, the Panel's April 5 th Order notes that 27 potentially related actions are pending in various federal courts at this time.